KR20190025307A - 고함량 오일 내상을 안정화한 수중유형 화장료 조성물 - Google Patents
고함량 오일 내상을 안정화한 수중유형 화장료 조성물 Download PDFInfo
- Publication number
- KR20190025307A KR20190025307A KR1020170111796A KR20170111796A KR20190025307A KR 20190025307 A KR20190025307 A KR 20190025307A KR 1020170111796 A KR1020170111796 A KR 1020170111796A KR 20170111796 A KR20170111796 A KR 20170111796A KR 20190025307 A KR20190025307 A KR 20190025307A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- composition according
- oil
- content
- semi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 85
- 239000002537 cosmetic Substances 0.000 title claims abstract description 43
- 239000008384 inner phase Substances 0.000 title claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 44
- 239000000839 emulsion Substances 0.000 claims abstract description 40
- 229940106189 ceramide Drugs 0.000 claims abstract description 28
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 26
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 26
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 26
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000004094 surface-active agent Substances 0.000 claims abstract description 23
- 235000011187 glycerol Nutrition 0.000 claims abstract description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 20
- 239000011734 sodium Substances 0.000 claims abstract description 20
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 239000004615 ingredient Substances 0.000 claims abstract description 14
- 230000007774 longterm Effects 0.000 claims abstract description 12
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 claims abstract description 9
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 claims abstract description 9
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 8
- 230000008591 skin barrier function Effects 0.000 claims abstract description 7
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 3
- 239000002245 particle Substances 0.000 claims description 28
- 239000007908 nanoemulsion Substances 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 16
- 239000012071 phase Substances 0.000 claims description 12
- 230000000087 stabilizing effect Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 238000004945 emulsification Methods 0.000 description 41
- 239000003921 oil Substances 0.000 description 33
- 235000019198 oils Nutrition 0.000 description 30
- 230000000052 comparative effect Effects 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 10
- 239000012669 liquid formulation Substances 0.000 description 7
- 150000001783 ceramides Chemical class 0.000 description 6
- 239000003876 biosurfactant Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- SGVYKUFIHHTIFL-UHFFFAOYSA-N 2-methylnonane Chemical compound CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 2
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- PDRAHDYJNDYBNK-UHFFFAOYSA-N n-[3-[hexadecanoyl(2-hydroxyethyl)amino]-2-hydroxypropyl]-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(=O)N(CCO)CC(O)CN(CCO)C(=O)CCCCCCCCCCCCCCC PDRAHDYJNDYBNK-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 238000010428 oil painting Methods 0.000 description 1
- -1 pack Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
도 2는 고압유화 직후, 비교예 3의 나노에멀젼 입자 크기 및 분포를 광학현미경으로 확인한 사진이다.
도 3은 실시예 1의 1차 유화 직후(왼쪽), 고압유화기 1회 통과 직후(가운데), 및 고압유화기 3회 통과 직후(오른쪽), 조성물 외관을 촬영한 사진이다.
도 4는 비교예 1의 1차 유화 직후, 조성물 외관을 촬영한 사진이다.
도 5는 실시예 1의 제조 직후(위) 및 상온 12개월 보관 후(아래), 나노에멀젼 입자 크기 값을 비교한 그래프이다.
| 성분 | 실시예 1 | 실시예 2 | 실시예 3 | 비교예 1 | 비교예 2 | 비교예 3 | |
| 수상 파트 | 물 | to 100 | to 100 | to 100 | to 100 | to 100 | to 100 |
| 글리세릴 카프릴레이트 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| 부틸렌글리콜 | 8 | 8 | 8 | 8 | 8 | 8 | |
| 글리세린 | 20 | 20 | 10 | 0 | 20 | 20 | |
| 소듐서팩틴 | 1 | 1 | 1 | 1 | 1 | 0 | |
| 소듐 스테아로일 글루타메이트 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 유상 파트 | 세라마이드 | 2 | 2 | 2 | 2 | 0 | 2 |
| 글리세릴 스테아레이트 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| PEG-100 스테아레이트 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| 세테아릴알코올 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| 세틸2-에틸헥사노에이트 | 2 | 10 | 10 | 10 | 10 | 10 | |
| 카프릴릭/카프릭 트리글리세라이드 | 3 | 10 | 10 | 10 | 10 | 10 | |
| 스쿠알란 | 5 | 10 | 10 | 10 | 10 | 10 | |
| 디메치콘 | 2 | 2 | 2 | 2 | 2 | 2 | |
Claims (13)
- 소듐서팩틴(Sodium Surfactin), 세라마이드(Ceramide) 및 글리세린(Glycerine)을 필수 성분으로 포함하여, 고압유화 제조 방법으로, 고함량 오일 내상을 안정화시켜 제조한, 반투명 액상 수중유형 화장료 조성물.
- 제 1항에 있어서, 상기 소듐서팩틴의 함량은 조성물 총 중량에 대하여 0.1 내지 5 중량%임을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항에 있어서, 상기 세라마이드의 함량은 조성물 총 중량에 대하여 0.1 내지 10 중량%임을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항에 있어서, 상기 글리세린의 함량은 조성물 총 중량에 대하여 5 내지 30 중량%임을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 4항에 있어서, 상기 글리세린의 함량은 조성물 총 중량에 대하여 10 내지 20 중량%임을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항에 있어서, 상기 고압유화 제조 방법은
i) 소듐서팩틴과 글리세린을 포함하는 수상 파트와 세라마이드를 포함하는 유상 파트를 각각 혼합하여 70℃까지 가온 및 용해한 다음, 호모 믹서 3000rpm으로 5분간 유화하여 불투명한 액상의 1차 에멀젼을 얻는 단계;
ii) i)단계에서 얻은 1차 에멀젼을 1000 내지 1500 bar의 압력 하에서 고압유화기에 2 내지 3회 통과시켜 균질화하여 최종 반투명한 나노에멀젼을 얻는 단계;
를 포함하는 것을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물. - 제 6항에 있어서, 상기 나노에멀젼의 입자 크기는 200nm 이하임을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항에 있어서, 상기 오일의 함량은 조성물 총 중량에 대하여 10 내지 40 중량%임을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항 내지 제 8항 중 어느 한 항에 있어서, 상기 조성물은 상온에서 12개월 이상의 장기 안정성을 유지하는 것을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항 내지 제 8항 중 어느 한 항에 있어서, 상기 조성물은 피부 장벽 개선 효과를 갖는 것을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항 내지 제 8항 중 어느 한 항에 있어서, 상기 조성물은 항염, 항균 효과를 갖는 것을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항 내지 제 8항 중 어느 한 항에 있어서, 상기 조성물은 피부 보습 효과를 갖는 것을 특징으로 하는, 반투명 액상 수중유형 화장료 조성물.
- 제 1항 내지 제 8항 중 어느 한 항에 있어서, 상기 반투명 액상 수중유형 화장료 조성물을 함유하는 화장료.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170111796A KR102451838B1 (ko) | 2017-09-01 | 2017-09-01 | 고함량 오일 내상을 안정화한 수중유형 화장료 조성물 |
| CN201880056396.8A CN111148505A (zh) | 2017-09-01 | 2018-08-31 | 稳定高含量油内相的水包油型化妆品组合物 |
| PCT/KR2018/010136 WO2019045515A1 (ko) | 2017-09-01 | 2018-08-31 | 고함량 오일 내상을 안정화한 수중유형 화장료 조성물 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170111796A KR102451838B1 (ko) | 2017-09-01 | 2017-09-01 | 고함량 오일 내상을 안정화한 수중유형 화장료 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20190025307A true KR20190025307A (ko) | 2019-03-11 |
| KR102451838B1 KR102451838B1 (ko) | 2022-10-11 |
Family
ID=65525975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170111796A Active KR102451838B1 (ko) | 2017-09-01 | 2017-09-01 | 고함량 오일 내상을 안정화한 수중유형 화장료 조성물 |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR102451838B1 (ko) |
| CN (1) | CN111148505A (ko) |
| WO (1) | WO2019045515A1 (ko) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102147604B1 (ko) * | 2019-05-23 | 2020-08-24 | 바이오인터체인지주식회사 | 소듐 서팩틴을 포함하는 탈모 방지 및 발모 촉진용 조성물 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114831896B (zh) * | 2022-05-17 | 2023-12-26 | 广州市百好博有限公司 | 一种抗水水包油型乳化剂组合物及其应用 |
| CN117122519A (zh) * | 2022-05-20 | 2023-11-28 | 上海如妍化妆品有限公司 | 一种水包油型化妆品材料组合物及其制备方法和应用 |
| CN116983238A (zh) * | 2023-08-11 | 2023-11-03 | 芳香世家化妆品(广州)有限公司 | 一种神经酰胺共输送纳米乳和屏障修护霜 |
| CN116850079A (zh) * | 2023-08-21 | 2023-10-10 | 北京华熙荣熙生物技术研究有限公司 | 一种乳液及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0181104B1 (ko) | 1996-12-26 | 1999-05-15 | 주식회사태평양 | 세라미드 유사 화합물 및 이의 제조방법 |
| KR100236304B1 (ko) | 1997-07-23 | 1999-12-15 | 서경배 | 세라미드 유사 화합물 및 이의 제조방법 |
| KR100452165B1 (ko) | 2002-01-29 | 2004-10-08 | 주식회사 태평양 | 리포펩티드계 보조 계면활성제를 이용한 나노에멀젼 및이를 함유하는 화장료 조성물 |
| KR20060121848A (ko) * | 2003-08-28 | 2006-11-29 | 쇼와 덴코 가부시키가이샤 | 화장품 |
| KR20130023912A (ko) * | 2011-08-30 | 2013-03-08 | 서울대학교산학협력단 | 나노 리포좀으로 안정화시킨 아미노산 또는 펩타이드 및 이를 이용한 기능성 화장료 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003277638A1 (en) * | 2002-11-15 | 2004-06-15 | Kose Corporation | Semitransparent cosmetics |
| TW200536561A (en) * | 2004-02-06 | 2005-11-16 | Showa Denko Kk | Method for stabilizing oil-based thickening gel composition |
| WO2005089708A1 (en) * | 2004-03-24 | 2005-09-29 | Showa Denko K.K. | Oil-in-water emulsified composition, and external preparation for skin and cosmetics using the composition |
| US9364413B2 (en) * | 2014-07-31 | 2016-06-14 | Umo International Co., Ltd. | Method for anti-aging treatment by surfactin in cosmetics via enhancing sirtuin |
| CN104739658B (zh) * | 2015-03-04 | 2017-11-03 | 上海应用技术学院 | 一种神经酰胺纳米乳液及其制备方法 |
| KR20170038249A (ko) * | 2015-09-30 | 2017-04-07 | (주)아모레퍼시픽 | 투명성이 개선된 고함량 세라마이드 나노 에멀젼, 이를 함유하는 화장료 조성물 및 이의 제조방법 |
-
2017
- 2017-09-01 KR KR1020170111796A patent/KR102451838B1/ko active Active
-
2018
- 2018-08-31 WO PCT/KR2018/010136 patent/WO2019045515A1/ko not_active Ceased
- 2018-08-31 CN CN201880056396.8A patent/CN111148505A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0181104B1 (ko) | 1996-12-26 | 1999-05-15 | 주식회사태평양 | 세라미드 유사 화합물 및 이의 제조방법 |
| KR100236304B1 (ko) | 1997-07-23 | 1999-12-15 | 서경배 | 세라미드 유사 화합물 및 이의 제조방법 |
| KR100452165B1 (ko) | 2002-01-29 | 2004-10-08 | 주식회사 태평양 | 리포펩티드계 보조 계면활성제를 이용한 나노에멀젼 및이를 함유하는 화장료 조성물 |
| KR20060121848A (ko) * | 2003-08-28 | 2006-11-29 | 쇼와 덴코 가부시키가이샤 | 화장품 |
| KR20130023912A (ko) * | 2011-08-30 | 2013-03-08 | 서울대학교산학협력단 | 나노 리포좀으로 안정화시킨 아미노산 또는 펩타이드 및 이를 이용한 기능성 화장료 조성물 |
Non-Patent Citations (1)
| Title |
|---|
| 1. Manjit Jaiswal etc, Nanoemulsion: an advanced mode of drug delivery system, 3 Biotech, April 2015, Volume 5, Issue 2, pp 123-127 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102147604B1 (ko) * | 2019-05-23 | 2020-08-24 | 바이오인터체인지주식회사 | 소듐 서팩틴을 포함하는 탈모 방지 및 발모 촉진용 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111148505A (zh) | 2020-05-12 |
| KR102451838B1 (ko) | 2022-10-11 |
| WO2019045515A1 (ko) | 2019-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102322706B1 (ko) | 고함량의 오일을 안정화시킨 나노에멀전 화장료 조성물의 제조방법 | |
| TW200520753A (en) | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer | |
| EP1140008A1 (de) | Kosmetische oder pharmazeutische lecithinhaltige gele oder niedrigviskose, lecithinhaltige o/w-mikroemulsionen | |
| KR101867847B1 (ko) | 재결정 입자를 갖는 수중유 유화 조성물 및 이를 포함하는 화장료 조성물 | |
| KR102451838B1 (ko) | 고함량 오일 내상을 안정화한 수중유형 화장료 조성물 | |
| KR20160117111A (ko) | 식물 유래 계면활성제를 포함하는 화장료 조성물 | |
| EP3441060B1 (en) | Nano-emulsion cosmetic composition in which high content oils are stabilized | |
| KR20180106106A (ko) | 유화 입자의 크기 편차를 개선한 수중유형(o/w) 에멀젼 화장료 조성물 및 이의 제조 방법 | |
| KR20180106778A (ko) | 고함량 오일을 안정화시킨 반투명 수중유형(o/w) 화장료 조성물 및 이의 제조방법 | |
| WO2015136784A1 (ja) | セラミド分散組成物 | |
| KR101910962B1 (ko) | 세라마이드 액정 조성물 및 이의 제조방법 | |
| KR101125922B1 (ko) | 저점도의 화장료 조성물 | |
| KR102381622B1 (ko) | 쌀겨왁스의 안정화 방법 및 고 함량의 쌀겨왁스를 안정화한 나노에멀젼을 함유하는 화장료 조성물 | |
| KR20190079201A (ko) | 투명성이 개선된 고함량 천연 오일을 함유한 나노 에멀젼 조성물, 이를 포함하는 화장료 조성물 및 이의 제조 방법 | |
| KR102499487B1 (ko) | 점증제 없이 점도 및 경도를 갖는 화장료 조성물 | |
| KR20160082054A (ko) | 유화제를 함유하지 않는 수중유 유화형 화장료 조성물 및 이의 제조방법 | |
| KR102248067B1 (ko) | 화장료 조성물 | |
| KR101038589B1 (ko) | 전상온도유화법을 이용하여 수중유형 에멀젼 제조 시 전상온도의 조절방법, 이를 통하여 제조한 o/w형 나노에멀젼 및 이를 함유하는 화장료 조성물 | |
| JPWO2017179356A1 (ja) | 過脂肪剤およびパーソナルケア組成物 | |
| EP2603194B1 (de) | Stabilisierte w/o-emulsionen | |
| KR101870512B1 (ko) | 고형 지질 나노입자로 안정화한 코디세핀을 함유하는 화장료 조성물 | |
| JP6242422B2 (ja) | 化粧品原料の製造方法 | |
| JP4553607B2 (ja) | 水中油型乳化香料組成物及びその製造方法 | |
| KR20150081932A (ko) | 수중유형 에멀젼 조성물 및 이의 제조방법 | |
| KR20200105337A (ko) | 세륨옥사이드를 포함하는 광차단용 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170901 |
|
| PG1501 | Laying open of application | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20200710 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20170901 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20220323 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20220916 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20221004 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20221004 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration |